Vitalograph is set to invest €10 million as it expands its operations and creates 100 new jobs in Clare and and another 100 in Limerick over the next two years.
As revealed in the Clare Champion last week, the company is to spread its investment over two centres in the Mid-West.
The company is opening new sites at Engine Innovate Building, Limerick and the Clare Technology Park, Ennis to accommodate the high value new jobs that will support the rapid growth of its global clinical trials and healthcare business.
A significant investment is also being made in its existing manufacturing plant in Ennis as Vitalograph brings the production of its consumables from Asia to Ireland to achieve efficiencies of scale, increase the stability in their supply line and reduce the overall carbon footprint of these essential medical accessories.
With a base in Ennis since 1974, Vitalograph is a global leader in respiratory diagnostics, developing and manufacturing innovative medical diagnostical devices for all levels of the respiratory healthcare sector, and delivering full-service clinical trial solutions to pharmaceutical companies around the world.
Vitalograph’s clinical trial solutions, which have doubled in the last two years, are recognized among the best in the world for drug trials with a respiratory focus, and they hold a unique position as being the only company in the world to offer objective cough monitoring to leading commercial pharmaceutical companies, biotech, and research organizations.
Speaking at the announcement, Minister of State Patrick O’Donovan, said “It’s great to see Vitalograph, having established a base in Ennis in 1974, continuing to grow and develop its operations and expand its mandate, creating more than 200 new jobs in the next two years.”
Frank Keane, CEO at Vitalograph, said “Our latest investment and expansion plans reflects our pioneering spirit as we continue to embrace new opportunities for Vitalograph and play a significant role in improving patient lives.
“Effective respiratory diagnostics tools underline and enable a proactive approach to healthcare. Through our innovation and dedication, we have become an important catalyst behind the efficacy of the respiratory therapies being developed by the world’s leading pharmaceutical companies and I would like to acknowledge the contribution our staff have made to our ongoing success.”
“We’re excited to open new offices in Limerick and Ennis. This gives us an opportunity to leverage the diverse talent pool in the mid-west region as we deliver on our purpose of making a real impact on the management of respiratory disease.
“We are grateful to Enterprise Ireland for their ongoing support, and we look forward to growing our workforce in Ennis and Limerick into the future,” he continued.
Owen Ryan has been a journalist with the Clare Champion since 2007, having previously worked with a number of other publications in Limerick, Cork and Galway. His first book will be published in December 2024.